Novo Nordisk A/S seems to have Eli Lilly and Co.’s number again. The Danish company has been scoring a victory on points in recent years against its erstwhile rival in the diabetes business, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback